25-Hydroxy vitamin D deficiency predicts inferior prognosis in Hodgkin lymphoma
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 105, 106580
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 29 references indexed in Scilit:
- Vitamin D3receptor is highly expressed in Hodgkin’s lymphomaBMC Cancer, 2012
- Vitamin D insufficiency and prognosis in chronic lymphocytic leukemiaBlood, 2011
- Vitamin D Insufficiency and Prognosis in Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2010
- Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn DiseaseJournal of Biological Chemistry, 2010
- Meta-analysis of vitamin D, calcium and the prevention of breast cancerBreast Cancer Research and Treatment, 2009
- Meta‐analysis: longitudinal studies of serum vitamin D and colorectal cancer riskAlimentary Pharmacology & Therapeutics, 2009
- High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant ChemotherapyJournal of Clinical Oncology, 2009
- Nonclassic Actions of Vitamin DThe Journal of Clinical Endocrinology & Metabolism, 2009
- Vitamin D and prevention of colorectal cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- 1α,25-Dihydroxyvitamin D 3 Inhibits Angiogenesis In Vitro and In VivoCirculation Research, 2000